P625: A PHASE 1B/2 STUDY OF NAVTEMADLIN COMBINED WITH ACALABRUTINIB IN BTK INHIBITOR NAÏVE PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)

Detalles Bibliográficos
Autores principales: Byrd, John C., Ali Bhat, Seema, Awan, Farrukh, Giri, Pratyush, Ratnasingam, Sumita, Hájek, Roman, Hess, Dagmar, Alves, Daniela, Maciej Zaucha, Jan, Shen, Annalise, Bilotti, Elizabeth, Mcgreivy, Jesse, P. Rothbaum, Wayne, Ciepluch, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428975/
http://dx.doi.org/10.1097/01.HS9.0000969404.19790.4a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428975/
http://dx.doi.org/10.1097/01.HS9.0000969404.19790.4a

Ejemplares similares